Overview At Waters, we develop innovative clinical and in vitro diagnostic (IVD) solutions that combine advanced LC-MS instrumentation, software, and laboratory workflows to improve patient outcomes worldwide. As a Principal Test Engineer within our Clinical Software Development organisation,
Overview As part of a multi‑year strategic initiative Waters Wilmslow is looking for an Instrument Control Software (ICS) Engineer who is looking for career growth, skill set expansion and increased experience. A successful candidate will join an
Overview As part of a multi‑year strategic initiative Waters Wilmslow is looking for an Instrument Control Software (ICS) Engineer who is looking for career growth, skill set expansion and increased experience. A successful candidate will join an
Overview Waters is seeking a Principal IVD Software Engineer to help shape the future of our LCMS Clinical and Diagnostic software portfolio. This is a highly influential individual contributor role suited to an experienced software engineer with deep expertise
Overview For this role in the Waters Advanced Diagnostics LC-MS R&D team, you will be responsible for providing scientific contribution which impacts product development and business outcomes and positions us as the leading specialty measurement company
Overview Join Waters Advanced Diagnostics and help shape the future of clinical diagnostics. As Project Manager, Clinical Software, you will lead the coordination of complex IVD development programmes, bringing together diverse teams to deliver innovative LC-MS diagnostic
OverviewJoin Waters Advanced Diagnostics and help shape the future of clinical LCMS diagnostics. As a Project Manager you will lead the coordination of complex IVD development programmes, bringing together diverse teams to deliver innovative LC-MS diagnostic
Overview Waters is seeking a strategic and commercially minded Business Development professional to establish and accelerate our presence in the rapidly growing GLP-1 market. This is a unique opportunity to manage the development of our GLP-1